* Immunome press release [https://seekingalpha.com/pr/20297808-immunome-reports-third-quarter-2025-financial-results-and-provides-business-update] (IMNM [https://seekingalpha.com/symbol/IMNM]): Q3 GAAP EPS of -$0.65.
* As of September 30, 2025, cash and cash equivalents totaled $272.6 million, including net proceeds of $44.9 million from two transactions under its at-the-market equity offering program. Immunome expects its current cash position to fund operations into 2027.
MORE ON IMMUNOME
* Immunome: SpringWorks Buyout Informs The Potential Upside Here [https://seekingalpha.com/article/4812416-immunome-stock-springworks-buyout-informs-potential-upside-here]
* Seeking Alpha’s Quant Rating on Immunome [https://seekingalpha.com/symbol/IMNM/ratings/quant-ratings]
* Historical earnings data for Immunome [https://seekingalpha.com/symbol/IMNM/earnings]
* Financial information for Immunome [https://seekingalpha.com/symbol/IMNM/income-statement]
Immunome GAAP EPS of -$0.65
Published 1 day ago
Nov 7, 2025 at 4:30 AM
Positive
Auto